Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Apollomics Inc., a clinical-stage biopharmaceutical company focused on oncology therapies, announced a $10 million private placement. The financing includes cash investments and conversion of convertible notes from insiders and accredited investors, supporting ongoing clinical trials of its lead drug candidate, vebreltinib, for treating non-small c…
Stran & Company, Inc. (NASDAQ: SWAG) announced its financial results for Q2 and the first half of 2026, reporting revenue growth, improved gross profit, and doubled EBITDA compared to the prior year. The Company expanded its enterprise footprint with significant new contracts and continued to improve profitability in its loyalty solutions segment. …
FocalTherics announced preliminary unaudited Q2 2026 financial results, showing significant revenue and gross margin growth in its continuing HIFU segment. The company is exiting its ESWL and Distribution segments, marking a strategic shift to focus on robotic focal therapy technology. Cash and equivalents totaled $21.5 million as of June 30, 2026,…
Two Democratic U.S. senators have asked two Belgian companies to explain the circumstances surrounding an 18-carat gold ring set with 321 diamonds that was presented to President Donald Trump. The gift was delivered weeks before the U.S. moved to exempt European natural diamonds from newly proposed Section 301 tariffs. The senators say the timing a…
Vornado Realty Trust is partnering with Rudin Management and an affiliate of Kenneth Griffin, founder and CEO of Citadel, to develop a 1.9 million square foot trophy office building at 350 Park Avenue in New York City. Citadel Enterprise Americas will anchor the building with a 15-year lease for 1.05 million square feet. The $6.2 billion project in…
Extreme Networks is trading well below its recent highs after a margin-driven pullback. The selloff discounts a platform transition toward cloud-native, software-defined networking and AI-enabled management. With $105M of free cash flow, a $3.12B market cap and double-digit revenue growth last year, this is a tactical long for investors willing to …
FocalTherics, a global leader in robotic energy-based therapies, has initiated a proposed underwritten public offering of American Depositary Shares (ADSs) on NASDAQ. The company plans to use the net proceeds to cover operating costs, capital expenditures, and general corporate purposes. The offering is subject to market conditions and includes an …
Artisan Partners Asset Management Inc. announced that its preliminary assets under management as of July 31, 2026 totaled $183.0 billion, with $94.3 billion in Artisan Funds and Artisan Global Funds and $88.7 billion in separate accounts and other AUM. The breakdown of AUM by strategy was detailed, with various investment teams managing different a…
Tandy Leather Factory announced its financial results for the second quarter of 2026, showing a 1.5% increase in revenue to $18.0 million and a significant rise in operating income by 722.9% year-over-year. The company improved gross margins to 64.8% and reported net income of $0.4 million compared to a net loss the previous year. Despite a reducti…
Arbor Realty Trust announced the closing of an $825 million commercial real estate mortgage loan securitization, issuing $730.1 million of investment grade notes and retaining $112.4 million in subordinate interests. Proceeds will be used to repay credit facility borrowings, cover transaction costs, and finance future loan originations. The securit…
DoubleDown Interactive announced strong Q2 2026 financial results, with revenue rising 11.2% year-over-year to $94.3 million and earnings per fully diluted common share increasing 50.5% to $13.27. Growth was driven by the acquisition of WHOW Games GmbH and notable expansion in its Direct-to-Consumer segment, which now accounts for over 50% of total…
Fold Holdings, Inc., the first publicly traded bitcoin financial services company, announced second quarter 2026 results reporting $6.1 million in revenue and a net loss of $9.7 million. The company eliminated $20 million of secured debt and expanded its Fold Credit Card program to over 2,000 cardholders in early access, doubling from the previous …
Fabrinet, a global provider of advanced optical packaging and precision manufacturing services, announced that its management team will present at the Rosenblatt 6th Annual Age of AI Technology Summit on August 18, 2026. The presentation will be available via live webcast and replay on the company's investor website.
Reed's, Inc. reported its second quarter 2026 financial results with net sales decreasing to $7.5 million from $9.5 million a year ago, driven by lower volumes from national customers. However, the company demonstrated operational improvements with gross profit increasing to $1.8 million and gross margin rising to 24% from 8%. Operating expenses an…
Ferrari trades at a premium, but recent Q2 strength, a raised 2026 guide, aggressive buybacks and the most complete product lineup in decades justify owning the stock. This trade idea lays out an actionable long with entry, stop and target for a long-term holding (180 trading days), explains the fundamental drivers and balances the bull case with c…
Sanara MedTech Inc. reported a 9% increase in net revenue to $28.1 million for Q2 2026 compared to Q2 2025, with strong gross margins of 93%. The company announced an expected acquisition by MiMedx, aiming to create a leading regenerative medicine company. Despite a slight net loss due to increased SG&A and interest expenses, Adjusted EBITDA improv…
Cardiff Oncology announced positive Phase 2 clinical trial results for onvansertib combined with FOLFIRI/bevacizumab in first-line RAS-mutated metastatic colorectal cancer at ASCO 2026. Following a successful End-of-Phase 2 meeting with the FDA, the company plans to initiate a Phase 3 registrational trial in early 2027, contingent on securing addit…
Firefly Aerospace announced its second-quarter 2026 financial results with record revenue of $117.7 million, a 659% year-over-year increase. The company secured over six contracts in Q2, including a $144 million NASA Commercial Lunar Payload Services contract for a rapid Moon lander mission and a $75 million subcontract supporting NASA's MoonFall m…
Quantinuum and Oracle announced a multi-year collaboration to make Quantinuum’s Helios quantum computer available through Oracle Cloud Infrastructure’s quantum service. Financial terms and a deployment date were not disclosed. Helios will run on-site within OCI, integrate under existing governance frameworks, and be hosted in a U.S.-based Oracle AI…
SINTX Technologies provided a mid-year 2026 business update highlighting progress in commercializing its FDA-cleared SiNAPTIC Foot & Ankle Implant System, expansion of its distribution network, additional capital raises, and growth in its industrial ceramics segment. The company is moving from technology development to commercial execution, investi…
Seer, Inc., a proteomics technology company, announced its second quarter 2026 financial results, reporting $3.1 million in revenue, a 23% decline year-over-year, driven by macroeconomic challenges and elongated sales cycles. Despite the revenue decline, gross margin remained solid at 49%, operating expenses and net loss decreased compared to the p…
Mineralys Therapeutics announced its second quarter 2026 financial results, including a strengthened balance sheet following a $150 million public offering and a $100 million tranche drawn on a $500 million term loan. The company is on track for FDA's PDUFA target date of December 22, 2026, for lorundrostat, an aldosterone synthase inhibitor target…
H&R Block reported fiscal 2026 financial results showcasing a 5% revenue increase to $3.95 billion, a 21% rise in net income from continuing operations, and a 29% increase in earnings per share. The company returned $714 million to shareholders through dividends and share repurchases, raising its quarterly dividend by 10%. For fiscal 2027, it proje…
SELLAS Life Sciences reported its Q2 2026 financial results, highlighting progress in its lead cancer drug candidates GPS and SLS009, both targeting acute myeloid leukemia (AML). The Phase 3 REGAL trial for GPS is nearing the critical 80th event for final analysis, potentially leading to FDA Biologics License Application submission. The Phase 2 tri…
Mobile Infrastructure Corporation reported its second quarter 2026 financial results with same-location revenue growth of 5.6% year-over-year and contract parking volumes increasing approximately 12%. Despite a slight decrease in total revenue due to recent asset sales, same-location net operating income rose 12%. The company paid down $4.5 million…
